Stay updated on Efgartigimod Safety & Efficacy in pSS Clinical Trial
Sign up to get notified when there's something new on the Efgartigimod Safety & Efficacy in pSS Clinical Trial page.

Latest updates to the Efgartigimod Safety & Efficacy in pSS Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoChange DetectedThe page now includes PubMed-linked study publication text in the Publications section, along with an informational note that it is auto-filled. The site revision indicator has been updated from v3.5.2 to v3.5.3.SummaryDifference0.3%

- Check20 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check27 days agoChange DetectedIQVIA Pty Ltd was added as a collaborator and Iqvia Pty Ltd was removed.SummaryDifference0.1%

- Check49 days agoChange DetectedRevision updated to v3.5.0; previous revision v3.4.3 was removed.SummaryDifference0.1%

- Check63 days agoChange DetectedThe page now displays Revision: v3.4.3 in the footer, replacing Revision: v3.4.2.SummaryDifference0.1%

- Check85 days agoChange DetectedPage revision updated from v3.4.1 to v3.4.2, representing a minor update with no impact on study content, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Efgartigimod Safety & Efficacy in pSS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efgartigimod Safety & Efficacy in pSS Clinical Trial page.